Pharmaceutical product cross-contamination: industrial and clinical pharmacy practice
Dar Es Salaam Medical Students' Journal · 22.05.2013 · 19 (2) · 17-19
DOI: 10.4314/dmsj.v19i2.5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dar Es Salaam Medical Students' Journal, online erschienen am 22.05.2013. Verfasst von E Mathia. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Therapeutic consultation by patients is made complete by drug management which is expected to solve the patients’ problems. Pharmaceutical product cross-contamination is a serious problem which has been detected as an obstacle towards successful therapeutic goals. In the pharmaceutical care of patients in developed countries, cross-contamination of drugs has been well addressed and controlled unlike in most developing countries including Tanzania. This review intends to provide insight into this problem, aiming at increasing awareness on the health impacts of crosscontamination on patients in order to promote preventive strategies employed in combating cross-contamination in both industrial and clinical pharmacy practice.
Zitieren
APA
Mathia, E. (2013). Pharmaceutical product cross-contamination: industrial and clinical pharmacy practice. Dar Es Salaam Medical Students' Journal, 19(2), 17-19. https://doi.org/10.4314/dmsj.v19i2.5
Vancouver
Mathia E. Pharmaceutical product cross-contamination: industrial and clinical pharmacy practice. Dar Es Salaam Medical Students' Journal. 2013;19(2):17-19. doi:10.4314/dmsj.v19i2.5
BibTeX
@article{Mathia2013,
author = {Mathia, E},
title = {Pharmaceutical product cross-contamination: industrial and clinical pharmacy practice},
journal = {Dar Es Salaam Medical Students' Journal},
year = {2013},
volume = {19},
number = {2},
pages = {17--19},
doi = {10.4314/dmsj.v19i2.5}
}
EUVIMED